|4Feb 17, 4:15 PM ET

Bookman Michael 4

4 · Immuneering Corp · Filed Feb 17, 2023

Insider Transaction Report

Form 4
Period: 2023-02-15
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
Transactions
  • Award

    Stock Option

    2023-02-15+143,000143,000 total
    Exercise: $4.25Exp: 2033-02-15Class A Common Stock (143,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2023, and will be fully vested and exercisable on January 1, 2027.

Documents

1 file
  • 4
    form4-02172023_040202.xmlPrimary